Traduction de «canadian association for williams syndrome » (Anglais → Français) :

Foundation for Prader-Willi Research Canada [ FPWR Canada | Canadian Prader-Willi Syndrome Association ]

Canadian Rett Syndrome Association

Witnesses: From the Canadian Finance & Leasing Association: David Powell, President; From the Canadian Automobile Dealers Association: Huw Williams, Director, Public Affairs; From the Canadian Vehicle Manufacturers' Association: David C. Adams, Secretary and Director; From the G.E. Capital Canada: Bob Weese, Vice-President; Roman Oryschuk, President and CEO; From the Canadian Payments Association: Robert Hammond, General Manager; Doug Kreviazuk, Director, Policy and Planning; From the INTERAC Association: Judith Wolfson, Presid ...[+++]ent; Fred Harris, Senior Vice-President; Marc-André Lacombe, Corporate Secretary and Legal Counsel; From the Compcorp: Alan E. Morson, President; Gordon M. Dunning, Executive Vice-President; From the Ontario Securities Commission: Tannis MacLaren, Associate General Counsel; From the Quebec Securities Commission: Jean Laurin, Director; Dianne Jolie, Director; Martin Martin, Chief.

Appearing today representing the Canadian Council of Criminal Defence Lawyers, is William Trudell, Chair; from the Ottawa Police Service, Maria Neill, Detective, Elder Abuse Unit; appearing by video conference from New Brunswick and on behalf of the Canadian Association of Social Workers is Morel Caissie, President; finally from the Registered Nurses Association of Ontario is Doris Grinspun, Chief Executive Officer.

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major comp ...[+++]lications associated with venous angioplasty" have occurred in Canada and, if it is not possible to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

We are now fortunate to have with us witnesses from the Canadian Bankers Association, Mr. William P. Randle, Assistant General Counsel and Foreign Bank Secretary, and Mr. William Crate, Director of Security.